Table 1 Patient characteristics at baseline

From: Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity

Characteristics

No. of patients

%

Total enrolled/evaluable

37/36

—

Age (years)

 Median

44

 

 Range

30–68

 

Menopausal status

 Premenopausal

25

69

 Postmenopausal

11

31

Clinical tumour size

 T2

22

61

 T3

9

25

 T4

5

14

Clinical nodal status

 N0

11

31

 N1

22

61

 N2

1

3

 N3

2

5

PgR status

 PgR negative/low

6

17

 PgR positivea

30

83

Ki67

 <20%

14

39

 ⩾20%

22

61

Nuclear grade

 1

1

3

 2

27

75

 3

6

17

 Unknown

2

5

  1. PgR=progesterone receptor.
  2. aPositive: ⩾10%.
Back to article page